Skip to main content
BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
At close: Nov 4, 2026

BioRegenx Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.771.852.343.412.443.99
Revenue Growth
-23.43%-20.75%-31.40%39.97%-38.88%-48.79%
Gross Profit
1.451.51.662.311.642.56
Operating Income
-0.38-0.52-6.55-3.41-1.89-3.25
Net Income
-1.3-1.54-23.05-3.6-2.22-4.72
Earnings Per Share
-0.00-0.00-0.03-0.01-0.06-0.13
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.050.070.060.130.620.88
Total Debt
2.172.212.161.491.633.51
Net Cash (Debt)
-2.12-2.15-2.11-1.36-1.01-2.62
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.03-0.07

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
0.030.04-0.32-1.52-2.09-3.93
Capital Expenditures
-0.01-0.01-0.19---0.03
Free Cash Flow
0.020.03-0.51-1.52-2.09-3.96
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
81.90%81.08%70.87%67.76%67.28%64.13%
Operating Margin
-21.30%-27.98%-279.93%-99.92%-77.40%-81.57%
Pretax Margin
-73.81%-83.23%-985.17%-105.53%-91.26%-118.37%
Profit Margin
-73.81%-83.23%-985.17%-105.53%-91.26%-118.37%
FCF Margin
1.07%1.61%-21.95%-44.41%-85.88%-99.39%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
5.15414.83----
PS Ratio
0.066.693.68---